Evaluation of a Supporting Transition and Resilience to Clinical Nursing Education (STRONG) Study

Sponsor
National University of Singapore (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06128889
Collaborator
(none)
300
1
6

Study Details

Study Description

Brief Summary

This study aims to address the following research questions:
  1. Evaluate the effectiveness of a Supporting Transition and Resilience to Clinical Nursing Education (STRONG) program on first year nursing students' anxiety, depression, stress, resilience, practice readiness, physical activity and eating behaviours.

  2. Explore first year nursing students' experiences and perception of the STRONG program.

Participants will be invited to participate in an asynchronous online STRONG program

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Supporting Transition and Resilience to Clinical Nursing Education (STRONG) Program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evaluation of a Supporting Transition and Resilience to Clinical Nursing Education (STRONG) Study - A Mixed Methods Evaluation
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: STRONG program

Behavioral: Supporting Transition and Resilience to Clinical Nursing Education (STRONG) Program
The STRONG program adopts an asynchronous online learning approach and will be delivered over one week by a trained counsellor, and a nurse researcher. Students will attend an online self-paced program. The program will comprise of topics such as: (1) Resilience and protective factors, (2) introduction to clinical nursing education, (3) experiences of clinical attachments, and (4) stress, physical wellbeing and diet materials. Students will have access to online materials (e.g., short videos), have opportunities to discuss (e.g., forum) and infographics. Overall, the program will be delivered over in one week lasting six hours.

Outcome Measures

Primary Outcome Measures

  1. Resilience [Before training]

    Brief Resilience Scale

  2. Resilience [Immediately after training]

    Brief Resilience Scale

  3. Resilience [1 month after training]

    Brief Resilience Scale

  4. Depression, Anxiety, and Stress [Before training]

    Depression, Anxiety and Stress Scale - 21

  5. Depression, Anxiety, and Stress [Immediately after training]

    Depression, Anxiety and Stress Scale - 21

  6. Depression, Anxiety, and Stress [1 month after training]

    Depression, Anxiety and Stress Scale - 21

  7. Practice Readiness [Before training]

    Nursing Practice Readiness Scale

  8. Practice Readiness [Immediately after training]

    Nursing Practice Readiness Scale

  9. Practice Readiness [1 month after training]

    Nursing Practice Readiness Scale

  10. Physical activity [Before training]

    International Physical Activity Questionnaire

  11. Physical activity [Immediately after training]

    International Physical Activity Questionnaire

  12. Physical activity [1 month after training]

    International Physical Activity Questionnaire

  13. Eating behaviours [Before training]

    International Physical Activity Questionnaire

  14. Eating behaviours [Immediately after training]

    International Physical Activity Questionnaire

  15. Eating behaviours [1 month after training]

    International Physical Activity Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • First year nursing students enrolled in the NUR1107B Nursing Practice Experience and NUR1202C Clinical Experience I module

  • Above the ages of 18 years

  • Able to comprehend the English language

  • Have a device that can connect to the Internet

Exclusion Criteria:
  • Students who refused to participate in this study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National University of Singapore

Investigators

  • Principal Investigator: Darryl Ang, PhD, National University of Singapore

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National University of Singapore
ClinicalTrials.gov Identifier:
NCT06128889
Other Study ID Numbers:
  • NUS-IRB-2023-737
First Posted:
Nov 13, 2023
Last Update Posted:
Nov 13, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2023